GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Common Stock

K Pharma (TSE:4896) Common Stock : 円854 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is K Pharma Common Stock?

K Pharma's quarterly common stock increased from Sep. 2023 (円100 Mil) to Dec. 2023 (円854 Mil) but then stayed the same from Dec. 2023 (円854 Mil) to Mar. 2024 (円854 Mil).

K Pharma's annual common stock stayed the same from Dec. 2021 (円100 Mil) to Dec. 2022 (円100 Mil) but then increased from Dec. 2022 (円100 Mil) to Dec. 2023 (円854 Mil).

K Pharma Common Stock Historical Data

The historical data trend for K Pharma's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

K Pharma Common Stock Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23
Common Stock
100.00 100.00 854.09

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24
Common Stock Get a 7-Day Free Trial 100.00 100.00 100.00 854.09 854.09

K Pharma Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

K Pharma (TSE:4896) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Common Stock
Comparable Companies
TSE:7776 TSE:4888 TSE:4594 TSE:4598 TSE:4588 TSE:4891 TSE:2370 TSE:3750 TSE:4583 TSE:4564 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
7-7-7 Roppongi, Minato-ku, Tokyo, JPN, 106-0032
Website
https://en.kpharma.co.jp
K Pharma Inc is a company involved in Research, development, manufacturing, sales and marketing of pharmaceutical products and regenerative medicine products. It is involved in studying of iPs cells in regnerative medecine to treat neurological conditions such as cerebral infarction and SCI.

K Pharma (TSE:4896) Headlines

No Headlines